EcoDrugPlus

Ensembl ID : ENSBMUG00000006000
Gene Symbol: -
Cross references: -
90 Possible Orthologues:

Ensembl ID : ENSBMUG00000020542
Gene Symbol: -
Cross references: -
72 Possible Orthologues:

Ensembl ID : ENSBMUG00000018793
Gene Symbol: -
Cross references: -
68 Possible Orthologues:

Ensembl ID : ENSBMUG00000015608
Gene Symbol: -
Cross references: -
137 Possible Orthologues:

Ensembl ID : ENSBMUG00000003294
Gene Symbol: -
Cross references: -
168 Possible Orthologues:

Ensembl ID : ENSBMUG00000003199
Gene Symbol: -
Cross references: -
170 Possible Orthologues:

Ensembl ID : ENSBMUG00000002279
Gene Symbol: -
Cross references: -
149 Possible Orthologues:

Ensembl ID : ENSBMUG00000012179
Gene Symbol: -
Cross references: -
73 Possible Orthologues:

Ensembl ID : ENSBMUG00000009173
Gene Symbol: -
Cross references: -
73 Possible Orthologues:

Ensembl ID : ENSBMUG00000022479
Gene Symbol: -
Cross references: -
142 Possible Orthologues:

Ensembl ID : ENSBMUG00000009939
Gene Symbol: -
Cross references: -
147 Possible Orthologues:

Ensembl ID : ENSBMUG00000026257
Gene Symbol: -
Cross references: -
169 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).